GlassScriptPhysician profile
Hoda Agrama
NPI 1861093197
$761.64
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $231 · 2023: $31.34 · 2024: $21.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.38 | 2021-2023 | Vraylar |
| Corium, LLC | $121.23 | 2021 | |
| Alkermes, INC. | $96.01 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $90.72 | 2021 | |
| Neos Therapeutics, LP | $35.52 | 2021 | |
| Hologic Sales and Service, LLC | $21.39 | 2024 | Aptima |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.66 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.38 | 2022 | |
| Viiv Healthcare Company | $14.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hoda Agrama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.